What Clues Help Distinguish Type 1 From Type 2 Diabetes?

Publication
Article
Consultant for PediatriciansConsultant for Pediatricians Vol 6 No 3
Volume 6
Issue 3

How can I tell the difference between type 1 and type 2 diabetes in children?

Q: How can I tell the difference between type 1 and type 2 diabetes in children?

A: At first glance, it would appear to be relatively easy to distinguish type 1 diabetes (T1D) from type 2 diabetes (T2D).

T1D, caused by autoimmune destruction of the pancreatic beta cells, typically presents with a relatively brief prodrome of increased thirst and urination. Weight loss is common, and up to one third of children with T1D present with ketoacidosis. T1D is more common in Caucasians of northern European background; the peak age at presentation is early adolescence, with a lesser peak in the group younger than 5 years.

T2D, which has been increasing steadily in the pediatric population during the past 10 years, is more prevalent in African American, Latino, and American Indian youth. T2D typically has a more insidious onset and is frequently diagnosed during routine screening. Weight loss is less common; indeed, obesity plays a significant role in the development of T2D in children. Insulin resistance from obesity (and perhaps underlying genetic factors) requires compensatory increases in insulin secretion to maintain normal glucose tolerance. Once the demand for insulin exceeds the capacity of the beta cell, overt diabetes occurs.1

Table – Differentiating type 1 from type 2 diabetes

 
Type 1 diabetes
Type 2 diabetes
Onset
Acute, symptomatic
Insidious, often asymptomatic
Clinical Presentation
Polyuria, polydipsia, weight loss
Obesity, acanthosis nigricans, polycystic ovary syndrome
Ketosis
Almost always present
Usually absent
Race/ethnicity
Caucasian
African Amercian, Latino, American Indian
Family history
Often absent
Usually present
Antibodies
ICA-,GAD-, ICA512-positive
ICA-,GAD-, ICA512-negative
Therapy
Insulin
Oral hypoglycemic agents



Despite their markedly disparate etiologies and seemingly different clinical presentations, however, it can be difficult to differentiate T1D from T2D in some children. For example:

•With the increasing prevalence of obesity among young people, more children with T1D are obese at presentation. It is also thought that the increased demands placed on the beta cell may accelerate the autoimmune destructive process in children with a genetic predisposition to T1D.2

•While ketoacidosis and pancreatic autoantibodies are classic indicators of T1D, it is now evident that some African American youth with T2D may present with diabetic ketoacidosis.3 Also, markers of autoimmunity may not be as reliable in some non-white populations with T1D.4

•It now appears that there may be some overlap in the diagnosis. In so-called double diabetes, children with clinical characteristics of T2D have autoimmune markers characteristic of T1D.5

•Monogenic forms of diabetes (maturity-onset diabetes of youth [MODY]), which typically occur in lean, Caucasian teens or young adults with a family history of diabetes, may easily be misdiagnosed as either T1D or T2D.6

So, what is the clinician to do? It is still reasonable to consider the typical clinical characteristics at presentation (Table), supplemented by appropriate laboratory testing at diagnosis in specific situations (eg, measurement of pancreatic autoantibodies to differentiate T1D from T2D in an African American adolescent, or molecular diagnostics to confirm MODY in a non-obese teenager with mild T2D).

With the availability of more therapeutic options for youth with diabetes--such as insulin sensitizers for T2D and sulfonylureas for MODY-the issue of classification of diabetes has never been more important.

References:

REFERENCES:


1.

Alberti G, Zimmet P, Shaw J, et al. Type 2 diabetes in the young: the evolving epidemic: the international diabetes federation consensus workshop.

Diabetes Care.

2004;27:1798-1811.

2.

Wilkin TJ. The accelerator hypothesis: weight gain as the missing link between Type I and Type II diabetes.

Diabetologia.

2001;44:914-922.

3.

Pinhas-Hamiel O, Dolan LM, Zeitler PS. Diabetic ketoacidosis among obese African-American adolescents with NIDDM.

Diabetes Care.

1997;20:484-486.

4.

Thai AC, Ng WY, Loke KY, et al. Anti-GAD antibodies in Chinese patients with youth and adult-onset IDDM and NIDDM.

Diabetologia.

1997;40:1425-1430.

5.

Libman IM, Becker DJ. Coexistence of type 1 and type 2 diabetes: "double" diabetes?

Pediatr Diabetes.

2003;4:110-113.

6.

Fajans SS, Bell GI, Polonsky KS. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young.

N Engl J Med.

2001;345: 971-980.

Related Videos
Discussing health care sustainability, climate change, and WHO's One Health goal | Image credit: Provided by Shreya Doshi
Willough Jenkins, MD
Screening for and treating the metatarsus adductus foot deformity |  Image Credit: UNFO md ltd
Wendy Ripple, MD
Wendy Ripple, MD
Courtney Nelson, MD
DB-OTO improved hearing to normal in child with profound genetic deafness | Image Credit: © Marija - © Marija - stock.adobe.com.
Carissa Baker-Smith
Perry Roy, MD
© 2024 MJH Life Sciences

All rights reserved.